BPS Activities

Meetings of the BPS

Every year two official meetings of BPS are held, at the FIP World Congress and in spring in The Hague, The Netherlands. The BPS meetings are well attended by the representatives of all PSMOs, PSOOs, BPS Expert Members and Chairs of the Special Interest Groups, showing that BPS is the global forum of the pharmaceutical scientists around the world. Excellent relationships have been built up with all PSMOs.

Unofficial BPS meetings are organized “on demand”, preferably in combination with a congress of a PSMO.  


Statements and publications  


BPS Policy Statements:

The following statements were originated by the BPS and adopted by FIP Council: 

  • FIP Statement of Principle on Pharmaceutical Research in Geriatric Subjects (Singapore, 2001)
  • FIP Position Paper on The Impact of Genomics on the Discovery and Development of Genetic Based Medicines - Genomics and Beyond (Singapore, 2001)
  • Medicines for Children (Basel, 2008)
  • Biosimilars (under preparation)
  • Therapeutic Interchangeability (under preparation) 

To view the statements in four FIP official languages (English, French, German and Spanish), click here.

Challenges and opportunities for pharmaceutical sciences:

The chairs of 8 (out of 9) Special Interest Groups of BPS have compiled opinions with regard to major challenges for the pharmaceutical sciences over the next 5-10 years. Areas covered are drug design and discovery, natural products, formulation design and pharmaceutical technology, pharmacokinetics/pharmacodynamics and systems pharmacology, translational and personalized medicine, biotechnology, analytical sciences and quality control, and regulatory science. It was published in 2015. To view the paper, click here.



Committee on the Pharmaceutical Sciences World Congress 2017 (PSWC 2017) in Stockholm

After having successfully organized the PSWC2014 in Melbourne, Australia in 2014, the BPS is now focusing on organizing, under the leadership of Prof. Meindert Danhof, a Pharmaceutical Sciences World Congress (PSWC) to be held in Stockholm, Sweden on 22-24 May 2017. 


Høst-Madsen Award Selection Committee:

The Høst-Madsen Award is the highest Scientific Award presented by the Board of Pharmaceutical Sciences. It is given bi-annually to a pharmaceutical scientist who has made outstanding contributions to pharmaceutical sciences. Click on FIP Awards in the left-hand menu for more information. The Selection Committee consists of:

Prof. Daan Crommelin (Chair)


The Netherlands

(Bio) Pharmaceutics

Prof. Andrew Somogyi



Clinical Pharmacology/Treatment of Addiction

Dr Ho-Leung Fung



drug metabolism and biochemical pharmacology

Prof. Jennifer Dressman





Dr Shiew-Mei Huang



Clinical Pharmacology/Regulatory Sciences

Prof. Peter Crooks



Drug Design and Discovery

Prof. Hitoshi Sasaki



Pharmacokinetics/Drug Delivery 

Dr Sandy Pang





The BPS is willing to offer to pharmaceutical scientists, great opportunities to educate on the new development of pharmaceutical sciences as well as to offer a forum for discussion.

As a consequence, for many years, BPS has been involved in two major kinds of congresses:

  • The Pharmaceutical Sciences World Congresses, which is a major international and high-level congress held every 3-4 years
  • The FIP Annual Congress, held every year, and gathering pharmacists and pharmaceutical scientists. 


Pharmaceutical Sciences World Congresses

Millennial World Congress of Pharmaceutical Sciences, San Francisco, 2000

The first Millennial World Congress was organized in San Francisco, USA in 2000 under the Chairmanship of Prof. Leslie Benet.  It was a successful scientific World Congress. It was decided to continue with such scientific conferences every three/four years.


PSWC Kyoto, 2004

The second Pharmaceutical Sciences World Congress, PSWC 2004, was organized under the leadership of Prof. Yuichi Sugiyama, in Kyoto, Japan, 31 May – 5 June 2004.  This conference was also a great success with the participation of 2,200 scientists from 46 countries.  The opening ceremony was highlighted by the presence of His Imperial Highness Prince Akishino and scientific presentations from Dr.Ryoji Noyori, a 2001 Nobel Laureate in Chemistry, and Dr. Louis J. Ignarro, a 1998 Nobel Laureate in Physiology or Medicine. There were 8 plenary lectures and 11 core topics with 35 scientific symposia.

PSWC Amsterdam, 2007

The third Pharmaceutical Sciences World Congress was organised in Amsterdam, April 22-25, 2007 under the Chairmanship of Prof. Daan Crommelin. A pre-satellite symposium was dedicated to the next generation of pharmaceutical scientists, where doctorate students and post-doctorate fellows from all over the world will convene in Amsterdam were able to exchange ideas and discuss the latest developments in pharmaceutical sciences. Over 2,500 scientists, researchers and academics attended this congress, which opening ceremony includes speeches of Dr Ronald Plasterk, who is the Dutch Minister of Education, Culture and Science, and of Dr Thomas Lönngren, Executive Director of EMEA.


PSWC New Orleans, 2010

The fourth PSWC took place from 14-18 November 2010 at the Morial Convention Center in New Orleans, (USA). It was organised under the Chairmanship of Dr Mario Rocci, in conjunction with AAPS Annual Meeting and Exhibition.

The general theme of the congress was "Improving Global Health Through Advances in Pharmaceutical Sciences".

This congress was attended by over 9000 pharmaceutical scientists. The keynote lecture was given by Dr. Tadataka “Tachi” Yamada, President of
the Bill & Melinda Gates Foundation Global Health Program.


PSWC Melbourne, 2014

The fifth Pharmaceutical Sciences World Congress (PSWC) took place in Melbourne, Australia, 13-16 April 2014. It was organised under the Chairmanship of Prof. Ross McKinnon, together with the help of the Director of the Monash Institute of Pharmaceutical Sciences, Prof. William Charman.

The general theme of the congress was ‘Pharmaceutical sciences – The rise of a new era in healthcare’.

This congress was attended by over 2000 pharmaceutical scientists. The opening ceremony was given by Peter C. Doherty AC, FAA, FRS - Nobel Laureate in Physiology or Medicine (1996) and Author. 


PSWC Stockholm, 2017

The sixth Pharmaceutical Sciences World Congress (PSWC) took place in Stocholm, Sweden, 21-24 May 2017. It was organised under the Chairmanship of Prof. Meindert Danhof from Leiden Academic Centre for Drug Research, Pharmacology

The general theme of the congress was Systems approaches for better medicines and health”.




FIP World Congresses

In addition to the Pharmaceutical Sciences World Congresses, the BPS organises many symposia on pharmaceutical sciences during the main FIP Congress.

At the last FIP Congress in Istanbul, the BPS organised the following symposia:

  • Nanomedicine
  • Individualization of Drug Therapy and Ethical Concerns
  • New Strategies in Modern Medicinal Chemistry
  • Contribution of pharmacovigilance to public health
  • Quality, Safety and Efficacy of Natural Products
  • Understanding the Dissolution Testing and IVIVC
  • Environment and Pharmaceuticals
  • Nuclear Pharmacy (Round Table)
  • The Future of Pharmaceutical Sciences in 2020

BPS/BPP Joint Symposium

In addition to the scientific programme, joint symposia between BPS and BPP addressing common interest were initiated in Singapore, 2001. Because of overwhelming interest the practice of hosting joint symposia has continued.

These symposia are meant to bridge the pharmaceutical sciences with professional practice, enabling dialogue and point of view sharing.At the last FIP congress, in Istanbul (Turkey), the theme was "Translational Sciences".


Interactions with WHO

The BPS has developed cooperation with the World Health Organization (WHO) in the field of pharmaceutical sciences.

WHO Technical Series

FIP/BPS has played a significant role in the development, rewrite and finalization of the document “Multisource (generic) pharmaceutical products: Guidelines on registration requirements to establish interchangeability” in WHO Technical series, No. 937, 2006. The document deals with bioequivalence requirements, conduct of bioequivalence studies and biowaiver based on Biopharmaceutics Classification System. More information can be obtained here.


Conferences and Workshops

The FIP-BPS has developed several kinds of workshops on specific topics, which are held at a national level, based on the request of member organizations.

Some of them, mentioned as FIP-BPS/AAPS, have been initiated in collaboration with the American Association of Pharmaceutical Scientists (AAPS), a predominantly scientific member organization.

Some outreach activities are also cosponsored with the Academy of Pharmaceutical Science and Technology of Japan (APSTJ) and of Japan.

These activities are focused towards increasing the pharmaceutical knowledge among scientists, improving regulatory standards aiming to improve the quality of medicines and facilitating the research and development.

These outreach activities have been focused towards developing countries, because of its greater impact.   Travel for these workshops is supported by FIP and/or AAPS or industry.  All local cost is absorbed by the local organization.


    A - International workshops:

         1. Bio-International conferences

They are held to discuss and resolve complex issues in BA/BE.  These discussions are held on a FIP-BPS neutral platform with academia, industry and regulators and to reach international understanding and harmonization.  The first such conference was initiated in 1989. Since then, such conferences were held in 1992, 1994, 1996, 1999, 2001, 2003 and 2005. Since 2005, it has been decided to hold such conferences in London in collaboration with Royal Pharmaceutical Society of Great Britain.

The last Bio-International conference was held on “Towards improved harmonization in regulating multisource products in London, October 22-24, 2008.


        2. Quality-International

The Quality-International Conference jointly organized by the BPP and the BPS aims to contribute to a more harmonized understanding of process criticality across the pharmaceutical industry

These conferences are intended to industrial pharmacists and colleagues (from pharmaceutical development and manufacturing, regulatory affairs, quality control, quality assurance etc.), to regulatory authorities and inspectorates, as well as academic colleagues.

 The two last editions were:

1.  Quality-International is being organized in London, November 21-22, 2005.

2.  Quality-International, London, November 2007


    B - FIP/BPS Outreach Activities:

        1. Regulatory Science Workshops.

The BPS organises in collaboration with the AAPS, Joint Regulatory Science Workshops aiming to provide solid knowledge and competences to participants from the regulatory, academic and industry in developing countries.

These workshops supported by the strong involvement of high-ranking FDA speakers and academicians have been so far extremely successful, attracting on an average 200 or more participants every time.

Regulatory Science workshops in the area of BA and BE were held in:

1. Mumbai, India (December 1998)
2. Cairo, Egypt (February 2000)
3. Jerusalem, Israel (February 2000)
4. Bangkok, Thailand (November 2000)
5. Taipei, China-Taiwan (November 2000)
6. Seoul, Republic of Korea (December 2000)
7. Potchefstroom, South Africa (May 2001) 
8. Santiago, Chile (April 2002)
9. Quito, Ecuador (November 2002)
10. São Paolo, Brazil (June 2003) 
11. Bucharest, Romania (December 2003)
12. Istanbul, Turkey (November/December 2004)
13. Pretoria, South Africa (May 2005)
14. Budapest, Hungary (October 2006)
15. Mexico City, Mexico (November 2006)
16. Smolensk, Russia (March 2007)
17. Caracas, Venezuela (June 2007)
18. Hanoi, Vietnam (October 2007)
19. Ho Chi Minh City, Vietnam (November 2007)
20. Istanbul, Turkey (March 2008)
21. Budapest, Hungary (June 2010)
22. Kobe, Japan (June/July 2011)

23. Ho Chi Minh City, Vietnam (March 2012)


        2. Hands-on-Dissolution workshops.


The quality of pharmaceuticals is still of great concern to FIP and WHO.  The dissolution test has emerged as a most powerful tool to assess the drug product quality and its in vivo performance.  The Dissolution WG of SIG BA/BE has initiated “Hands-on-Dissolution” workshops in collaboration with WHO to improve the drug product quality, especially in developing countries. These types of workshops have been organized in:

1. Melbourne, Australia (July 1999)
2. Mumbai and Bangalore, India (January 2001)
3. Ho-Chi-Minh, Vietnam (March 2003)
4. Bangkok, Thailand (March 2003)
5. Beijing and Shanghai, China (April 2004)
6. Bucharest, Romania (October 2005)
7. Istanbul, Turkey (October 2005)
8. Warsaw, Poland (June 2007)
9. Ho Chi Minh City, Viet Nam (November 2007)
10. Montevideo, Uruguay (November 2008)
11. Porto Alegre, Brazil (May 2010)


        3. FIP – BPS/AAPS Tutorial Workshops

The educational – tutorial workshops have been organized in the following rapidly developing countries:

1. Beijing, China (2002) – Pharmaceutical Sciences
2. Mumbai, India (2004) – Changing scenario in cGMP regulations
3. Goa, India (2004) – Scientific and regulatory aspects of bioequivalence: A to Z
4. Nanjing, China (2004) – Pharmaceutical Sciences
5. Mumbai, India (2005) – Drug discovery and development
6. Mumbai, India (2006) Biotechnology


        4.  Biotechnology symposia/workshops.

1. Cairo, Egypt (2005)
2. Santiago, Chile (2005)
3. Taipei, China-Taiwan (2006)
4. Buenos Aires, Argentina (2006)
5. Antalya, Turkey (2006)
6. Istanbul, Turkey (2007) 


        5. FIP Quality Workshops

1. Pharmaceutical Quality and GMP for 21st Century.  Mumbai, India (2008)